At the news
? NEUTRALIMPACT 2/10 144 filed Jun 2, 2026 at 16:58 ET
Charles Divita III, a director of Teladoc Health, filed a Form 144 notice of intent to sell 19,132 shares of common stock, valued at approximately $145,920. The shares were acquired on June 1, 2026, through restricted stock vesting as compensation. This is a routine insider sale to cover tax obligations from equity vesting, not a discretionary market sale.
- Director Charles Divita III filed a Form 144 to sell 19,132 shares of TDOC common stock.
- Estimated sale value is approximately $145,920 based on the filing date.
- Shares were acquired on June 1, 2026, via restricted stock vesting as compensation.
- The sale is intended to cover tax obligations from the vesting of an equity award.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access